Case Commentary On Sun Pharmaceutical Industries Ltd. V. Cipla Ltd., Appl. Nos. 1980, 1982 & 1983 Of 2021
Pratyus Sarangi, Bennett University
In the case of Sun Pharmaceutical Industries Ltd. v. Cipla Ltd., two major pharmaceutical giants of India, i.e., Sun Pharma and Cipla locked horns over a trademark dispute. This case was a classic modernistic development in the domain of trademark infringement, which came in the backdrop of COVID-19 outbreak. This case analyses the opportunistic approach of putting forward socio-legal contentions in order to get away with legal obligations.
The instant matter includes a dispute where Sun Pharma, the applicant/defendant, has allegedly infringed the registered trademark of the respondent/plaintiff, i.e., Cipla Ltd., by manufacturing and selling deceptively similar drugs in the backdrop of pandemic, when the entire country was facing extraordinary demands of related drugs and the supply of such drugs were scarce.